What is Autonomize?
Autonomize operates at the intersection of healthcare technology and enterprise-grade artificial intelligence. The company provides a sophisticated platform designed to structure unstructured healthcare data, thereby enabling healthcare organizations to orchestrate complex workflows through specialized AI agents. By integrating human expertise with machine learning, Autonomize addresses critical inefficiencies in the healthcare sector, positioning itself as a vital player in the digital health ecosystem.
The firm's market position is defined by its focus on intelligence and decision support, which are essential for modernizing healthcare delivery. As the industry shifts toward value-based care, Autonomize's ability to provide operational insights and automate administrative burdens makes it a key partner for health systems and providers seeking to improve clinical outcomes and operational performance.
How much funding has Autonomize raised?
Autonomize has raised a total of $32M across 2 funding rounds:
Angel/Seed
$4M
Series A
$28M
Angel/Seed (2023): $4M with participation from The Next Practices Group
Series A (2025): $28M led by ATX Venture Partners, Cigna, Asset Management, Valtruis, and Tau Ventures
Key Investors in Autonomize
ATX Venture Partners
An early-stage venture capital firm based in Austin, Texas, specializing in disruptive B2B software, APIs, and frontier technology.
Cigna
A global health company committed to improving health and vitality through innovative solutions and comprehensive health services.
Valtruis
A platform that invests in and partners with disruptive leaders to transform the healthcare industry through value-based care models.
What's next for Autonomize?
With the successful closure of this Series A round, Autonomize is poised to scale its operations and expand its footprint within the healthcare technology landscape. The strategic backing from a diverse group of investors—ranging from venture capital firms to global health organizations—provides the company with both the financial runway and the industry expertise necessary to navigate the complexities of the healthcare market.
Looking ahead, the company is expected to focus on enhancing its AI-native agent capabilities and deepening its integration within existing clinical workflows. By prioritizing the development of scalable, secure, and compliant technology, Autonomize aims to solidify its role as a foundational layer for the next generation of healthcare intelligence. The focus will likely remain on driving adoption among large-scale enterprise clients who require robust, data-driven solutions to manage the increasing volume and complexity of modern medical information.
